Update shared on15 Aug 2025
With consensus forecasts for Katapult Holdings’ future P/E and revenue growth remaining steady, analysts have maintained their price target at $10.50.
What's in the News
- Katapult Holdings will hold a Special/Extraordinary Shareholders Meeting to seek approval for the issuance of common stock upon exercise of warrants and conversion of a term loan, in compliance with Nasdaq Listing Rules.
- Shareholders will also consider the option to adjourn or postpone the meeting to solicit additional proxies if necessary, and address any other business brought before the meeting.
Valuation Changes
Summary of Valuation Changes for Katapult Holdings
- The Consensus Analyst Price Target remained effectively unchanged, at $10.50.
- The Future P/E for Katapult Holdings remained effectively unchanged, at 1.30x.
- The Consensus Revenue Growth forecasts for Katapult Holdings remained effectively unchanged, at 15.0% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.